Mustang Bio, Inc.
MBIO
$0.61
-$0.02-3.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 87.80% | 90.03% | 89.78% | 73.28% | 69.47% |
| Total Depreciation and Amortization | -95.02% | -89.56% | -88.30% | -91.86% | -63.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -196.43% | -111.96% | -134.21% | -40.44% | -36.04% |
| Change in Net Operating Assets | -195.90% | -181.27% | -217.54% | 199.54% | 158.97% |
| Cash from Operations | 53.87% | 66.74% | 75.93% | 79.78% | 76.94% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -80.58% | -80.58% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 3,983.33% | -80.32% | -80.21% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 31.03% | 83.62% | 36.12% | 293.32% | 137.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28.95% | 89.23% | 40.02% | 172.34% | 143.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7,291.03% | 335.25% | 169.74% | 121.91% | 99.79% |